![BalkoResearchLab Profile](https://pbs.twimg.com/profile_images/1719453239840837633/5Hmw9PO6_x96.jpg)
BalkoResearchLab
@BalkoLab
Followers
681
Following
867
Statuses
649
We are the Balko Research Lab at VUMC, a translational cancer research lab at the interface of tumor biology and immunotherapy. Opinions RR own.
Nashville, TN
Joined February 2019
Looks amazing! Great work @ECBrunner!
Check out this article that made the 2025 cover of Cancer Research Communications: Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast Cancer @BalkoLab
0
0
0
@Nole2death @apolo_andrea Cars were invented in the 1880s and remain today the most frequent use of transportation. There have been no advances in transportation in the last 150 years. Chemotherapy is a broad term for literally 100s of drugs, most discovered in the last 40. It's cool, good work. 👍🏼
0
0
0
RT @SABCSSanAntonio: State of the Art: The Winding Road of Immune Biomarkers in Early Breast Cancer—Roberto Salgado, Justin Balko, and Priy…
0
7
0
RT @SABCSSanAntonio: State of the Art: The Winding Road of Immune Biomarkers in Early Breast Cancer— Roberto Salgado, Justin Balko, and Pri…
0
1
0
RT @HanZhuMD: Next, @MargaretAxelrod talks about patient and tumor specific biomarkers in ici myocarditis👌 #gcos #gcos24 @ICOSociety @Balko…
0
6
0
RT @AmirZMunir: As we better understand mechanisms that may drive ICI-myocarditis, we can think of more targeted therapies! Work by many in…
0
1
0
RT @VUMCHemOnc: Amazing 🤩@VUMChealth @VUMCDiscoveries @VUMC_Cancer representation @asco #ASCO24! 👏👏👏@benhopark @jordanberlin5 @KimrynRathm…
0
7
0
RT @DFCI_BreastOnc: #ASCO24 Poster Session | Analysis of the sensitivity to endocrine therapy assay in the PALLAS adjuvant trial of palboci…
0
2
0
@StoverLab @ASCO @OSUCCC_James @FilipaLynce @DFCI_BreastOnc @AngieDemichele @PennCancer @DrSGraff @BrownUCancer Congrats Dan!!!
0
0
1
RT @SusanGKomen: Komen grantee @BalkoLab presents his work on understanding and improving #breastcancer response to immunotherapy @ #AACR24…
0
3
0
RT @VUMC_VCI: This is no joke! On April 1, the HTIP and TRIO @VUMC_Cancer programs will host its 2nd Annual Retreat in📍214 Light Hall from🕐…
0
6
0
So proud of this outstanding scientist and person @BCT255 defending her thesis today. A @SusanGKomen ASPIRE scholar, @CD_AACR @jitcancer published author and all around superstar. Can't wait to see what the future holds!! @VUMCResearch @VUBasicSciences
0
5
20
RT @BReinfeld: Great talk with wonderful implications for the next generation of myeloid therapy in ccRCC. Can’t w…
0
2
0
RT @CD_AACR: From the latest issue— #NKG2A is a Therapeutic Vulnerability in #Immunotherapy Resistant MHC-I Heterogeneous Triple Negative #…
0
5
0
Super excited for next year's meeting! Only 290 days and counting (OK you got me... I didn't do the math I just guessed 😂)
We thank our program committee for creating a great #SABCS24 lineup. @VKaklamani @CarlosArteagaMD @BalkoLab @tperrybrown @heide_ford @HarrisLabUTHSA @TariKingMD @lab_kok @Adrianvlee @itsnot_pink @hmcarthur @dapattmd @c_sotiriou @atanmdlci @NeilVasan @adawaksmd @awolff @AACR_CEO
0
0
5
Excited to see the *official* version out!!! Great job by the editorial staff... It looks phenomenonal!
From the February issue— #NKG2A is a Therapeutic Vulnerability in #Immunotherapy Resistant MHC-I Heterogeneous Triple Negative #BreastCancer, by @BCT255, @SXPung, @BalkoLab et al. @VUMCDiscoveries #TNBC
0
1
15